Skip to main content

Table 2 Comparison of N-terminal pro-brain natriuretic peptide level between IVIG-resistance and IVIG-response group stratified by age

From: The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study

  IVIG-resistance group IVIG-response group P
Overall (n = 393) 54 339  
Age (month) 28.50 [14.00–57.00] 24.00 [13.00–42.00] 0.051
NT-ProBNP 2685 [551.50–7010.00] 975.00 [387.00–2560.00] 0.006*
< 1 year (n = 79) 8 71  
Age (month) 7 [4–8] 7 [5–8] 0.941
NT-ProBNP 3950.00 [1745.00–6252.50] 1130.00[471.00–2790.00] 0.012*
1–2 years (n = 109) 14 95  
Age (month) 16.50 [13.75–20.25] 17.00 [14.00–20.00] 0.923
NT-ProBNP 2290.00 [494.75–5347.50] 1080.00 [472.00–2580.00] 0.001*
2–6 years (n = 176) 23 153  
Age (month) 39.00 [29.00–54.00] 38.00 [30.00–49.00] 0.491
NT-ProBNP 3770.00 [528.00–8800.00] 798.00 [305.00–2085.00] < 0.001*
> 6 years (n = 29) 9 20  
Age (month) 83.00 [76.00–94.50] 86.00 [80.00–101.50] 0.308
NT-ProBNP 609.00 [207.00–9775.00] 2110.00 [369.75–9742.50] 0.822
  1. The data are presented as the median with the 25th and 75th percentiles in square brackets for continuous variables
  2. IVIG, intravenous immunoglobulin; NT-ProBNP, N-terminal probrain natriuretic peptide;
  3. *Statistically significant (P < 0.05)